this study was designed to ascertain whether individuals with mood disorders are particularly vulnerable to adverse effects of aspartamealthough the protocol required the recruitment of 40 patients with unipolar depression and a similar number of individuals without a psychiatric history the project was halted by the institutional review board after a total of 13 individuals had completed the study because of the severity of reactions within the group of patients with a history of depressionin a crossover design subjects received aspartame 30 mgkgday or placebo for 7 daysdespite the small n there was a significant difference between aspartame and placebo in number and severity of symptoms for patients with a history of depression whereas for individuals without such a history there was notwe conclude that individuals with mood disorders are particularly sensitive to this artificial sweetener and its use in this population should be discouraged